While myelination and oligodendrocyte differentiation have been previously implicated in AD pathogenesis17, we link these processes to changes in a specific oligodendrocyte population in APOE E4+ carriers of middle age with no clinical signs of AD. Here, APOE is linked to Alzheimer disease.